TrialMedicina (Kaunas, Lithuania)2023

Ivabradine for the Prevention of Anthracycline-Induced Cardiotoxicity in Female Patients with Primarily Breast Cancer: A Prospective, Randomized, Open-Label Clinical Trial.

Eglė Čiburienė et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.